Last week Flexible
Solutions International, Inc. (FSI:
NYSE) reviewed financial results for its fiscal
year ending December 2015. Apparently, it
was not a banner year for this producer of biodegradable polymers, including ingredients
for oil extraction, detergents and water treatment. Most of its customers are in the oil and gas
industry, which is experiencing a particularly deep downturn. A flooding situation in Texas led to a reduction
in demand for the company’s WaterSavr
product. Consequently, the company
indicates that sales in 2015 were near $15.9 million, which is flat compared the
previous fiscal year.
Investors will
not get a look at the details until the end of March 2016, when Flexible
Solutions files its annual report with the SEC.
In the meantime, we have results for the first nine months of 2015. The company has reported $12.2 million in
total sales in the first nine months of 2015, compared to $12.0 million in the
same period in the previous year. Investors
might not have been thrilled with the tepid top-line performance, but a strong
increase in net income to $1.1 million or $0.08 had been impressive against the
reported $421,403 or $0.03 in the previous year.
With this trend
etched in investors’ minds, it is understandable why Flexible Solutions
management wanted to come clean on slipping sales as soon as possible. In the announcement last week the company
disclosed that sales declined 6% year-over-year in the quarter ending December
2015. Shareholders will be on pins and
needles for the next two months wondering if the slip in sales also means a
slip in profits.
Flexible Solution
has not been sitting by idly waiting for it primary oil and gas target market to
recover. The company has clocked in
increased sales of its biodegradable polymers (BCPAs) to alternative markets
such as agriculture and industry.
Farmers can use the BCPAs to enhance fertilizer uptake by crop
plants. The company’s BCPAs can also be
used to make detergents biodegradable. Consequently, sales of BCPAs in the first
nine months of 2015 increased 3.3% year-over-year. It was
actually weak sales of water conservation products that have been the source of
disappointment, declining by 19.3% in the first nine months of 2015 compared to
the same period the year before.
Management has
also shown its ‘flexibility’ through a cost reduction program. Suspension of operations at the company’s
aspartic acid plant in Taber, Canada and a move to more modest headquarters
helped trim operating costs. The company
had been planning to produce its own aspartic acid production using a
sugar-based process. The economics of
this choice have been in flux as production costs in Canada increased while
aspartic acid prices from historic suppliers in China have declined.
Investors will
need to be as flexible as management.
The stock had been on a steady climb since late October 2015, on
relatively encouraging fundamental news reach investors. However, last week as news of the top-line
disappointment reached traders, FSI price sold off on above average volume. On the final day of trading last week, FSI
fell below the 50-day moving average stock price.
Contrarian
investors, who believe FSI is now oversold, but find this a compelling
opportunity to accumulate shares.
Unfortunately, it might be a long wait to recovery. It is unclear whether the U.S. equity market
as achieved full capitulation. There may
be even lower prices and heavier trading volume in our future. That means FSI is not near recovery and could
even trade to lower levels. Then there
is that promised announcement at the end of March 2016, when Flexible Solutions
provides all the details of its troubles last year.
We also expect management
to finally provide guidance on how sales have been trending in the first months
of the year. Disappointing guidance
could leave FSI trading more like an option on recovery rather than the value
of future cash flows. That might be even
more interesting for investors who like owning an environmentally sound
specialty chemical company like Flexible Solutions.
Neither the author of the Small Cap Strategist web
log, Crystal Equity Research nor its affiliates have a beneficial interest in
the companies mentioned herein.
No comments:
Post a Comment